Understand the advantages and challenges of investigator-initiated clinical trials, including funding constraints, regulatory burden, and...
Niche crafted a strategic communications plan for ApaTech's synthetic bone graft portfolio, translating preclinical science into compelling manuscripts, regulatory documents and conference publications ahead of its $330 million acquisition.



































